Dosage Form: Injection.
Indications: Cardiac decompensation.
Description: The clinical formulation is supplied in a sterile form for intravenous use only.
Ingredients: Each mL contains: Dobutamine hydrochloride, equivalent to12.5 mg (41.5? Mol) dobutamine; Sodium Bisulfite 0.28 mg (added during manufacture), and water for injection, q. S. Hydrochloric acid and/or sodium hydroxide may have been added during manufacture to adjust the pH (2.5 to 5.5).